Perforin-mediated lysis of tumor cells by Mycobacterium bovis Bacillus Calmette-Guérin-activated killer cells.

  title={Perforin-mediated lysis of tumor cells by Mycobacterium bovis Bacillus Calmette-Gu{\'e}rin-activated killer cells.},
  author={Sven Brandau and Henrik Suttmann and Josef Riemensberger and Ulrike Seitzer and Josh Arnold and Christoph Durek and Dieter Jocham and H. D. Flad and Andreas Boehle},
  journal={Clinical cancer research : an official journal of the American Association for Cancer Research},
  volume={6 9},
Immunotherapy with Bacillus Calmette-Guérin (BCG) is clinically established in the treatment of superficial bladder cancer. In our attempt to clarify the underlying immunological mechanism, we could previously show that stimulation of PBMC with BCG leads to the generation of cytotoxic BCG-activated killer (BAK) cells. Among others, these BAK cells as well as lymphokine-activated killer (LAK) cells have been suggested as possible effector cells during BCG therapy. To understand BCG-induced… CONTINUE READING


Publications citing this paper.
Showing 1-10 of 29 extracted citations


Publications referenced by this paper.
Showing 1-10 of 57 references

Induction ofBacillus Calmette-Guérin-activated killer cells from human peripheral blood mononuclear cells against human bladder carcinoma cell linesin vitro

  • A. Thanhäuser, A. Böhle, +4 authors A. J. Ulmer
  • Cancer Immunol. Immunother.,
  • 1993
Highly Influential
7 Excerpts

American Association for Cancer Downloaded from activities of novel recombinant tumor necrosis factor having N-terminal amino acid sequences derived

  • G. Soma, Y. Tsuji, +6 authors D. Mizuno
  • Clinical Cancer Research Research. on July
  • 2000

Immunological mechanism of BCG-immunotherapy: tumor cells are killed by perforin-releasing NK cells

  • S. Brandau, K. Reib, +5 authors A. Böhle
  • Eur. Urol.,
  • 1999
3 Excerpts

Similar Papers

Loading similar papers…